Respiratory
Latest Innovations |
---|
|
|
|
A Pro-Apoptotic Microbial Community Network Enriched in the Tissue of IPF and Lung Cancer Patients
Dr. Isaac Cann from the University of Illinois has identified biomarkers and therapeutic strategy for treatment of...
Dr. Isaac Cann from the University of Illinois has identified biomarkers and therapeutic strategy for treatment of idiopathic pulmonary fibrosis (IPF) and lung cancer. This strategy has the potential to dramatically improve the lives of millions patients throughout the world. It is the first know effective treatment route for Benefit • Treatment strategies including broad spectrum antibiotics may be effective for treating IPF and preventing lung cancer |
|
|
|
|